Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for toxoplasmosis testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Toxoplasmosis Testing Market Size (2024E): USD 2.2 Billion
• Projected Market Value (2033F): USD 3.5 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Toxoplasmosis Testing Market - Report Scope:

Toxoplasmosis testing plays a crucial role in diagnosing and managing infections caused by the parasite Toxoplasma gondii. These tests include serological assays, molecular diagnostics, and imaging techniques aimed at detecting antibodies or the presence of the parasite itself in various clinical specimens. The market caters to hospitals, clinics, diagnostic laboratories, and research institutions, offering a range of testing methods such as PCR, ELISA, and imaging modalities.

Market Growth Drivers:

The global toxoplasmosis testing market is driven by several key factors, including increasing awareness about toxoplasmosis as a significant health concern, particularly for pregnant women and immunocompromised individuals. The rising incidence of toxoplasmosis infections, fueled by factors such as changing dietary habits and pet ownership trends, further propels market expansion. Technological advancements in diagnostic techniques, such as the development of rapid molecular assays and automated platforms, enhance diagnostic accuracy and workflow efficiency, driving market growth. Moreover, expanding healthcare expenditure and supportive government initiatives aimed at improving infectious disease management contribute to market development.

Market Restraints:

Despite promising growth prospects, the toxoplasmosis testing market faces challenges related to accessibility to testing facilities in rural and underserved areas, particularly in developing regions. Regulatory hurdles and varying reimbursement policies for toxoplasmosis testing procedures also pose constraints on market penetration. Additionally, concerns regarding the accuracy of diagnostic tests and the asymptomatic nature of toxoplasmosis infections in many cases impact testing rates and market growth potential.

Market Opportunities:

The toxoplasmosis testing market presents significant growth opportunities driven by technological innovations in diagnostic platforms, increasing healthcare awareness campaigns, and the integration of point-of-care testing solutions. The adoption of telemedicine and remote diagnostic services also broadens market reach, particularly in geographically dispersed populations. Furthermore, strategic collaborations between diagnostic companies, healthcare providers, and public health agencies to improve testing accessibility and affordability are crucial for market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the toxoplasmosis testing market globally?
• Which diagnostic methods and technologies are leading the toxoplasmosis testing adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the toxoplasmosis testing market?
• Who are the key players contributing to the toxoplasmosis testing market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global toxoplasmosis testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global toxoplasmosis testing market, including Roche Diagnostics, Thermo Fisher Scientific, and Bio-Rad Laboratories, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic assays, expand their geographical presence, and enhance market penetration. Collaboration with healthcare providers, academic institutions, and regulatory bodies facilitates product approvals and market access, driving technological innovation and market growth.

Key Companies Profiled:

• Abbott Laboratories
• Bio-Rad Laboratories Inc
• Affymetrix Inc.
• Beckman Coulter Inc.
• Biotest
• Cepheid Inc.
• GenBio
• Danaher Corporation
• Thermo Fisher Scientific
• Biomerica Inc.
• Biomerix

Key Segments of Toxoplasmosis Testing Industry Research

Test Type:
• Serological Tests
• ELISA
• PCR
• Ultrasound
• MRI
• Biopsy

Sample:
• Blood Samples
• Amniotic Fluid
• Cerebrospinal Fluid

End User:
• Hospitals
• Clinics
• Diagnostic Laboratories

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions
3. Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption Analysis
4.2. Product Usage Analysis
4.3. Regulatory Framework
4.4. Recent Product Approvals/Launches
4.5. Porter’s Analysis
4.6. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Per Capita Healthcare Spending
5.1.2. Global Life Expectancy Outlook
5.1.3. Global Research and Development Funding Outlook
5.1.4. Global Infectious Disease Testing Market (Parent Market Analysis)
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing prevalence of toxoplasmosis
5.2.2. Evolving healthcare policies and clinical guidelines
5.2.3. Advancements in Diagnostic Technologies
5.2.4. Research and Development
5.2.5. Public Health Campaigns
5.2.6. Pregnancy Care Emphasis
5.2.7. Regulatory Approvals
5.2.8. Patient Awareness and Education
5.2.9. Emerging Healthcare Markets
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Million) Analysis 2019-2023 and Forecast, 2024-2033
6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
6.2. Historical Market Value (US$ Million) Analysis, 2019-2023
6.3. Current and Future Market Value (US$ Million) Projections, 2024-2033
6.3.1. Y-o-Y Growth Trend Analysis
6.3.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Test Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Test Type, 2019-2023
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2024-2033
7.3.1. Serological Test
7.3.1.1. Dye Test
7.3.1.2. Indirect Hemagglutination Assay
7.3.1.3. Direct agglutination Assay
7.3.2. ELISA
7.3.3. PCR
7.3.4. Ultrasound
7.3.5. MRI
7.3.6. Biopsy
7.4. Market Attractiveness Analysis By Test Type
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Sample
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis, By Sample, 2019-2023
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample, 2024-2033
8.3.1. Blood Sample
8.3.2. Amniotic Fluid
8.3.3. Cerebrospinal Fluid
8.4. Market Attractiveness Analysis By Sample
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis, By End User, 2019-2023
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2024-2033
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Diagnostic Laboratories
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis, By Region, 2019-2023
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2024-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2019-2023 and Forecast 2024-2033
11.1. Introduction
11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
11.3.1. By Country
11.3.1.1. United States
11.3.1.2. Canada
11.3.2. By Test Type
11.3.3. By Sample
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Test Type
11.4.3. By Sample
11.4.4. By End User
11.5. Market Trends
11.6. Market Drivers & Restraints – Impact Analysis
11.7. Country Level Analysis & Forecast
11.7.1. United States Market
11.7.1.1. Introduction
11.7.1.2. Market Analysis and Forecast by Market Taxonomy
11.7.1.2.1. By Test Type
11.7.1.2.2. By Sample
11.7.1.2.3. By End User
11.7.2. Canada Market
11.7.2.1. Introduction
11.7.2.2. Market Analysis and Forecast by Market Taxonomy
11.7.2.2.1. By Test Type
11.7.2.2.2. By Sample
11.7.2.2.3. By End User
12. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of LATAM
12.3.2. By Test Type
12.3.3. By Sample
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Test Type
12.4.3. By Sample
12.4.4. By End User
12.5. Market Trends
12.6. Market Drivers & Restraints – Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. Brazil Market
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast by Market Taxonomy
12.7.1.2.1. By Test Type
12.7.1.2.2. By Sample
12.7.1.2.3. By End User
12.7.2. Mexico Market
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast by Market Taxonomy
12.7.2.2.1. By Test Type
12.7.2.2.2. By Sample
12.7.2.2.3. By End User
12.7.3. Argentina Market
12.7.3.1. Introduction
12.7.3.2. Market Analysis and Forecast by Market Taxonomy
12.7.3.2.1. By Test Type
12.7.3.2.2. By Sample
12.7.3.2.3. By End User
13. Europe Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. United Kingdom
13.3.1.2. Germany
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Test Type
13.3.3. By Sample
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Test Type
13.4.3. By Sample
13.4.4. By End User
13.5. Market Trends
13.6. Market Drivers & Restraints – Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. United Kingdom Market
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast by Market Taxonomy
13.7.1.2.1. By Test Type
13.7.1.2.2. By Sample
13.7.1.2.3. By End User
13.7.2. Germany Market
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast by Market Taxonomy
13.7.2.2.1. By Test Type
13.7.2.2.2. By Sample
13.7.2.2.3. By End User
13.7.3. France Market
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast by Market Taxonomy
13.7.3.2.1. By Test Type
13.7.3.2.2. By Sample
13.7.3.2.3. By End User
13.7.4. Italy Market
13.7.4.1. Introduction
13.7.4.2. Market Analysis and Forecast by Market Taxonomy
13.7.4.2.1. By Test Type
13.7.4.2.2. By Sample
13.7.4.2.3. By End User
13.7.5. Spain Market
13.7.5.1. Introduction
13.7.5.2. Market Analysis and Forecast by Market Taxonomy
13.7.5.2.1. By Test Type
13.7.5.2.2. By Sample
13.7.5.2.3. By End User
13.7.6. BENELUX Market
13.7.6.1. Introduction
13.7.6.2. Market Analysis and Forecast by Market Taxonomy
13.7.6.2.1. By Test Type
13.7.6.2.2. By Sample
13.7.6.2.3. By End User
13.7.7. Russia Market
13.7.7.1. Introduction
13.7.7.2. Market Analysis and Forecast by Market Taxonomy
13.7.7.2.1. By Test Type
13.7.7.2.2. By Sample
13.7.7.2.3. By End User
14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Test Type
14.3.3. By Sample
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Test Type
14.4.3. By Sample
14.4.4. By End User
14.5. Market Trends
14.6. Market Drivers & Restraints – Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. China Market
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Test Type
14.7.1.2.2. By Sample
14.7.1.2.3. By End User
14.7.2. Japan Market
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Test Type
14.7.2.2.2. By Sample
14.7.2.2.3. By End User
14.7.3. South Korea Market
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast by Market Taxonomy
14.7.3.2.1. By Test Type
14.7.3.2.2. By Sample
14.7.3.2.3. By End User
15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Thailand
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Test Type
15.3.3. By Sample
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Test Type
15.4.3. By Sample
15.4.4. By End User
15.5. Market Trends
15.6. Market Drivers & Restraints – Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. India Market
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Test Type
15.7.1.2.2. By Sample
15.7.1.2.3. By End User
15.7.2. Indonesia Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Test Type
15.7.2.2.2. By Sample
15.7.2.2.3. By End User
15.7.3. Thailand Market
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Test Type
15.7.3.2.2. By Sample
15.7.3.2.3. By End User
15.7.4. Malaysia Market
15.7.4.1. Introduction
15.7.4.2. Market Analysis and Forecast by Market Taxonomy
15.7.4.2.1. By Test Type
15.7.4.2.2. By Sample
15.7.4.2.3. By End User
16. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Test Type
16.3.3. By Sample
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Test Type
16.4.3. By Sample
16.4.4. By End User
16.5. Market Trends
16.6. Market Drivers & Restraints – Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. Australia Market
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Test Type
16.7.1.2.2. By Sample
16.7.1.2.3. By End User
16.7.2. New Zealand Market
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Test Type
16.7.2.2.2. By Sample
16.7.2.2.3. By End User
17. Middle East & Africa Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Türkiye
17.3.1.3. South Africa
17.3.1.4. Northern Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Test Type
17.3.3. By Sample
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Test Type
17.4.3. By Sample
17.4.4. By End User
17.5. Market Trends
17.6. Market Drivers & Restraints – Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. GCC Countries Market
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Test Type
17.7.1.2.2. By Sample
17.7.1.2.3. By End User
17.7.2. Türkiye Market
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Test Type
17.7.2.2.2. By Sample
17.7.2.2.3. By End User
17.7.3. South Africa Market
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Test Type
17.7.3.2.2. By Sample
17.7.3.2.3. By End User
17.7.4. Northern Africa Market
17.7.4.1. Introduction
17.7.4.2. Market Analysis and Forecast by Market Taxonomy
17.7.4.2.1. By Test Type
17.7.4.2.2. By Sample
17.7.4.2.3. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Maternity Care Products)
18.2. Market Share Analysis of Top Players
18.3. Market Concentration
19. Competition Analysis
19.1. Competition Dashboard
19.2. Branding and Promotional Strategies, By key Players
19.3. Key Development Analysis
19.4. Competition Deep Dive
19.4.1. Abbott Laboratories
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Key Financials
19.4.1.4. SWOT Analysis
19.4.1.5. Key Developments
19.4.1.6. Sales Footprint
19.4.1.7. Strategy Overview
19.4.1.7.1. Marketing Strategy
19.4.1.7.2. Product Strategy
19.4.1.7.3. Channel Strategy
19.4.2. Bio-Rad Laboratories Inc
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Key Financials
19.4.2.4. SWOT Analysis
19.4.2.5. Key Developments
19.4.2.6. Sales Footprint
19.4.2.7. Strategy Overview
19.4.2.7.1. Marketing Strategy
19.4.2.7.2. Product Strategy
19.4.2.7.3. Channel Strategy
19.4.3. Affymetrix Inc.
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Key Financials
19.4.3.4. SWOT Analysis
19.4.3.5. Key Developments
19.4.3.6. Sales Footprint
19.4.3.7. Strategy Overview
19.4.3.7.1. Marketing Strategy
19.4.3.7.2. Product Strategy
19.4.3.7.3. Channel Strategy
19.4.4. Beckman Coulter Inc.
19.4.4.1. Overview
19.4.4.2. Product Portfolio
19.4.4.3. Key Financials
19.4.4.4. SWOT Analysis
19.4.4.5. Key Developments
19.4.4.6. Sales Footprint
19.4.4.7. Strategy Overview
19.4.4.7.1. Marketing Strategy
19.4.4.7.2. Product Strategy
19.4.4.7.3. Channel Strategy
19.4.5. Biotest
19.4.5.1. Overview
19.4.5.2. Product Portfolio
19.4.5.3. Key Financials
19.4.5.4. SWOT Analysis
19.4.5.5. Key Developments
19.4.5.6. Sales Footprint
19.4.5.7. Strategy Overview
19.4.5.7.1. Marketing Strategy
19.4.5.7.2. Product Strategy
19.4.5.7.3. Channel Strategy
19.4.6. Cepheid Inc.
19.4.6.1. Overview
19.4.6.2. Product Portfolio
19.4.6.3. Key Financials
19.4.6.4. SWOT Analysis
19.4.6.5. Key Developments
19.4.6.6. Sales Footprint
19.4.6.7. Strategy Overview
19.4.6.7.1. Marketing Strategy
19.4.6.7.2. Product Strategy
19.4.6.7.3. Channel Strategy
19.4.7. GenBio
19.4.7.1. Overview
19.4.7.2. Product Portfolio
19.4.7.3. Key Financials
19.4.7.4. SWOT Analysis
19.4.7.5. Key Developments
19.4.7.6. Sales Footprint
19.4.7.7. Strategy Overview
19.4.7.7.1. Marketing Strategy
19.4.7.7.2. Product Strategy
19.4.7.7.3. Channel Strategy
19.4.8. Danaher Corporation
19.4.8.1. Overview
19.4.8.2. Product Portfolio
19.4.8.3. Key Financials
19.4.8.4. SWOT Analysis
19.4.8.5. Key Developments
19.4.8.6. Sales Footprint
19.4.8.7. Strategy Overview
19.4.8.7.1. Marketing Strategy
19.4.8.7.2. Product Strategy
19.4.8.7.3. Channel Strategy
19.4.9. Thermo Fisher Scientific
19.4.9.1. Overview
19.4.9.2. Product Portfolio
19.4.9.3. Key Financials
19.4.9.4. SWOT Analysis
19.4.9.5. Key Developments
19.4.9.6. Sales Footprint
19.4.9.7. Strategy Overview
19.4.9.7.1. Marketing Strategy
19.4.9.7.2. Product Strategy
19.4.9.7.3. Channel Strategy
19.4.10. Biomerica Inc.
19.4.10.1. Overview
19.4.10.2. Product Portfolio
19.4.10.3. Key Financials
19.4.10.4. SWOT Analysis
19.4.10.5. Key Developments
19.4.10.6. Sales Footprint
19.4.10.7. Strategy Overview
19.4.10.7.1. Marketing Strategy
19.4.10.7.2. Product Strategy
19.4.10.7.3. Channel Strategy
19.4.11. Biomerix
19.4.11.1. Overview
19.4.11.2. Product Portfolio
19.4.11.3. Key Financials
19.4.11.4. SWOT Analysis
19.4.11.5. Key Developments
19.4.11.6. Sales Footprint
19.4.11.7. Strategy Overview
19.4.11.7.1. Marketing Strategy
19.4.11.7.2. Product Strategy
19.4.11.7.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology